Evidence map›Paper›PMID 42325682›Full record

ArticleFrontiers in cardiovascular medicine2026

Intracardiac thrombus formations despite continuous oral anticoagulation in atrial fibrillation patients undergoing catheter ablation procedures: pilot development of a machine learning prediction model.

F Ratajczak, F Hohendanner, S Haack, L Boldt, A S Parwani, F Blaschke, M Schneider-Reigbert, F Spinka, M Bock, A Meyer and 3 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

F Ratajczak *Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
F Hohendanner *Deutsches Herzzentrum der Charité, Klinik, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
S HaackCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
L BoldtDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
A S ParwaniDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
F BlaschkeDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
M Schneider-ReigbertDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
F SpinkaDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
M BockDeutsches Herzzentrum der Charité, Klinik, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
A MeyerCharité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
E HeilDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
G HindricksDeutsches Herzzentrum der Charité, Klinik, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
D SchoeppenthauDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Atrial fibrillation (AF) increases the risk of stroke, primarily due to thrombus formations (TF) in the left atrium (LA), especially in advanced atrial disease. Undetected TF despite continuous oral anticoagulation remain a safety concern, particularly in patients undergoing AF catheter ablations (CA) procedures. This retrospective study aimed to develop a machine learning (ML) model to predict TF in those patients. Methods: A retrospective cohort of 1335 AF patients who underwent CA and transesophageal echocardiography were screened for TF. Initially, Results: We analyzed 149 patients undergoing LA CA procedures on DOACs 96.0%/VKA 4.0%. The TF+ patients (20% solid thrombi, 80% prethrombotic formations) had a mean CHA₂DS₂-VASc of 3.89 and were in clinical arrhythmias in 96.9% at the time of TF, seen in a TOE performed before planned CA. The ML models showed a good performance in recognizing TF in the test-dataset, achieving a ROC AUC of 0.886 and 0.826 which outperformed CHA₂DS₂-VASc in our cohort (AUC 0.641). Some P-wave-characteristics in SR are ranked among the top ML features. Conclusion: ML algorithms, including echo parameters and p-Wave parameters reflecting atrial substrate, offer a promising approach for accurate prediction of TF in anticoagulated AF patients undergoing CA. Further validation could enable implementation of a clinically applicable risk stratification tool to enhance preprocedural decision-making.

Indexed as

atrial fibrillationcatheter ablationleft atrial thrombusmachine learningoral anticoagulation

Identifiers

PMID42325682
PMCPMC13275220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.